289 related articles for article (PubMed ID: 11071886)
1. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90.
Xu W; Mimnaugh E; Rosser MF; Nicchitta C; Marcu M; Yarden Y; Neckers L
J Biol Chem; 2001 Feb; 276(5):3702-8. PubMed ID: 11071886
[TBL] [Abstract][Full Text] [Related]
2. Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2.
Xu W; Mimnaugh EG; Kim JS; Trepel JB; Neckers LM
Cell Stress Chaperones; 2002 Jan; 7(1):91-6. PubMed ID: 11892991
[TBL] [Abstract][Full Text] [Related]
3. ErbB2 degradation mediated by the co-chaperone protein CHIP.
Zhou P; Fernandes N; Dodge IL; Reddi AL; Rao N; Safran H; DiPetrillo TA; Wazer DE; Band V; Band H
J Biol Chem; 2003 Apr; 278(16):13829-37. PubMed ID: 12574167
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha.
Marcu MG; Doyle M; Bertolotti A; Ron D; Hendershot L; Neckers L
Mol Cell Biol; 2002 Dec; 22(24):8506-13. PubMed ID: 12446770
[TBL] [Abstract][Full Text] [Related]
5. Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.
Xu W; Yuan X; Xiang Z; Mimnaugh E; Marcu M; Neckers L
Nat Struct Mol Biol; 2005 Feb; 12(2):120-6. PubMed ID: 15643424
[TBL] [Abstract][Full Text] [Related]
6. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
[TBL] [Abstract][Full Text] [Related]
7. Specific association of a set of molecular chaperones including HSP90 and Cdc37 with MOK, a member of the mitogen-activated protein kinase superfamily.
Miyata Y; Ikawa Y; Shibuya M; Nishida E
J Biol Chem; 2001 Jun; 276(24):21841-8. PubMed ID: 11278794
[TBL] [Abstract][Full Text] [Related]
8. ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin.
Smith V; Hobbs S; Court W; Eccles S; Workman P; Kelland LR
Anticancer Res; 2002; 22(4):1993-9. PubMed ID: 12174876
[TBL] [Abstract][Full Text] [Related]
9. Intracellular retention and degradation of the epidermal growth factor receptor, two distinct processes mediated by benzoquinone ansamycins.
Supino-Rosin L; Yoshimura A; Yarden Y; Elazar Z; Neumann D
J Biol Chem; 2000 Jul; 275(29):21850-5. PubMed ID: 10806200
[TBL] [Abstract][Full Text] [Related]
10. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome.
Loo MA; Jensen TJ; Cui L; Hou Y; Chang XB; Riordan JR
EMBO J; 1998 Dec; 17(23):6879-87. PubMed ID: 9843494
[TBL] [Abstract][Full Text] [Related]
11. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.
Schulte TW; Neckers LM
Cancer Chemother Pharmacol; 1998; 42(4):273-9. PubMed ID: 9744771
[TBL] [Abstract][Full Text] [Related]
12. Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. II. Ligand-mediated activation of GRP94 molecular chaperone and peptide binding activity.
Wassenberg JJ; Reed RC; Nicchitta CV
J Biol Chem; 2000 Jul; 275(30):22806-14. PubMed ID: 10816560
[TBL] [Abstract][Full Text] [Related]
13. Cofactor Tpr2 combines two TPR domains and a J domain to regulate the Hsp70/Hsp90 chaperone system.
Brychzy A; Rein T; Winklhofer KF; Hartl FU; Young JC; Obermann WM
EMBO J; 2003 Jul; 22(14):3613-23. PubMed ID: 12853476
[TBL] [Abstract][Full Text] [Related]
14. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent.
Whitesell L; Sutphin PD; Pulcini EJ; Martinez JD; Cook PH
Mol Cell Biol; 1998 Mar; 18(3):1517-24. PubMed ID: 9488468
[TBL] [Abstract][Full Text] [Related]
15. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate.
Thulasiraman V; Matts RL
Biochemistry; 1996 Oct; 35(41):13443-50. PubMed ID: 8873613
[TBL] [Abstract][Full Text] [Related]
16. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome.
An WG; Schulte TW; Neckers LM
Cell Growth Differ; 2000 Jul; 11(7):355-60. PubMed ID: 10939589
[TBL] [Abstract][Full Text] [Related]
17. The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells.
Xu W; Yuan X; Jung YJ; Yang Y; Basso A; Rosen N; Chung EJ; Trepel J; Neckers L
Cancer Res; 2003 Nov; 63(22):7777-84. PubMed ID: 14633703
[TBL] [Abstract][Full Text] [Related]
18. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.
Bonvini P; Gastaldi T; Falini B; Rosolen A
Cancer Res; 2002 Mar; 62(5):1559-66. PubMed ID: 11888936
[TBL] [Abstract][Full Text] [Related]
19. Geldanamycin selectively targets the nascent form of ERBB3 for degradation.
Gerbin CS; Landgraf R
Cell Stress Chaperones; 2010 Sep; 15(5):529-44. PubMed ID: 20084478
[TBL] [Abstract][Full Text] [Related]
20. Geldanamycin, an hsp90/GRP94-binding drug, induces increased transcription of endoplasmic reticulum (ER) chaperones via the ER stress pathway.
Lawson B; Brewer JW; Hendershot LM
J Cell Physiol; 1998 Feb; 174(2):170-8. PubMed ID: 9428803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
